Drug Channels

MARCH 15, 2022

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Drug Channels

OCTOBER 10, 2023

reviews the evolving specialty pharmacy industry and discusses emerging challenges from direct distribution models that bypass wholesale distribution. There are loads of internal hyperlinks to help you navigate the document and customize it to your specific interests and priorities. and Section 6.4.3. A new Section 6.2.2.

Specialty Pharmacies 40

Specialty Pharmacies Biosimilars Pharmaceutical Manufacturing Documentation 40

Ramblings of a pharmacist

DECEMBER 27, 2024

We can also see from this excerpt that at the scale of large PBMs, formulary strategies are also a piece of negotiating leverage to obtain rebates and fees from pharmaceutical manufacturers. However, once negotiations are completed and rebate contracted executed, rebates can be cut off punitively by pharmaceutical manufacturers.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Specialty Pharmacies Documentation Hospitals 98